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Periosteum contains skeletal stem cells with high
bone regenerative potential controlled by Periostin
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Bone regeneration relies on the activation of skeletal stem cells (SSCs) that still remain poorly
characterized. Here, we show that periosteum contains SSCs with high bone regenerative
potential compared to bone marrow stromal cells/skeletal stem cells (BMSCs) in mice.
Although periosteal cells (PCs) and BMSCs are derived from a common embryonic
mesenchymal lineage, postnatally PCs exhibit greater clonogenicity, growth and differentia-
tion capacity than BMSCs. During bone repair, PCs can efﬁciently contribute to cartilage and
bone, and integrate long-term after transplantation. Molecular proﬁling uncovers genes
encoding Periostin and other extracellular matrix molecules associated with the enhanced
response to injury of PCs. Periostin gene deletion impairs PC functions and fracture
consolidation. Periostin-deﬁcient periosteum cannot reconstitute a pool of PCs after injury
demonstrating the presence of SSCs within periosteum and the requirement of Periostin in
maintaining this pool. Overall our results highlight the importance of analyzing periosteum
and PCs to understand bone phenotypes.
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The skeleton is a central component of vertebrates’ body,providing structural support and protection for majororgans. The 206 bones constituting the human skeleton
store vital minerals, form muscle attachments, and comprise the
niche for hematopoiesis. Bones are constantly challenged
mechanically and can remodel or regenerate throughout life. The
development, growth, and regeneration of this essential organ
system rely on two robust ossiﬁcation processes, intramem-
branous ossiﬁcation occurring by direct differentiation of
mesenchymal precursors into osteoblasts and endochondral
ossiﬁcation marked by the formation of an intermediate cartilage
template1. Vascular invasion of this cartilage template drives the
replacement of cartilage by the bone marrow cavity and bone.
During this crucial step of skeletal development, hematopoietic
stem cells (HSCs) migrate into the developing bone to establish
their niche within the marrow cavity. In parallel, bone-forming
cells distribute in various bone compartments along the inner
surface of bone (endosteum), metaphyseal trabeculae, and on the
outer surface of the bone within the periosteum. It is well
established that these two processes of ossiﬁcation can be reca-
pitulated postnatally to very efﬁciently repair injured bones2–5.
This reactivation of the skeletogenic program requires the
re-expression of key transcription factors and growth factors
regulating skeletal development. Yet the skeletal stem cells (SSCs)
that permit this regenerative process and the mechanisms of stem
cell activation in response to bone injury remain elusive.
Research on the biology of SSCs has mostly concentrated until
now on the characterization of bone marrow stromal cells/skeletal
stem cells (BMSCs), that form the niche for HSCs, regulate bone
turnover, and show multipotency and self-renewal capacities after
subcutaneous transplantation6–11. SSC populations are very het-
erogeneous, making it a challenge to identify speciﬁc markers to
trace these cells in vivo. Recent advances with genetic mouse
models have identiﬁed several markers to deﬁne various sub-
populations of SSCs that appear during limb development and
post-natal growth, and play a role in bone maintenance and
repair12–22. However, these markers do not distinguish the tissue
origins of activated SSCs in response to bone injury. Although
BMSCs are largely used for enhancing bone repair through cell-
based therapy, it has become clear that BMSCs are not the central
cellular component of endogenous skeletal repair. In contrast, the
periosteum is largely involved in bone strength maintenance and
its preservation is crucial for normal bone repair23–31. The
periosteum is a thin layer of vascularized tissue lining the bone
surface, supporting the tendon and muscle attachments, and
highly responsive to mechanical stress. Several studies have
revealed the periosteum as a major source of SSCs for bone repair,
but this population has been largely overlooked until now30,32,33.
We hypothesized that bone marrow and periosteum comprise
SSC populations with distinct functions in bone biology and
speciﬁcally during endogenous bone repair.
Here we uncover common embryonic origins of BMSCs and
periosteal cells (PCs), but increased regenerative capacities and
long-term integration of PCs during bone regeneration in mice.
Periosteum grafting shows that a pool of PCs is reconstituted and
maintained within periosteum in response to injury and can be
re-activated after subsequent injuries revealing the presence of
SSCs within periosteum. Molecular proﬁling of PCs and BMSCs
in response to injury identiﬁes speciﬁc factors expressed in the
extracellular matrix (ECM) of periosteum, including Periostin.
Bone repair is compromised in Periostin KO mice due to
impaired periosteum and PC functions. Unlike wild-type peri-
osteum, Periostin-deﬁcient periosteum cannot reconstitute a pool
of PCs and contribute to healing after successive bone injuries
causing severe repair defects. Periostin is, therefore, a key
regulator of SSCs in periosteum and their niche.
Results
PCs and BMSCs share speciﬁc markers. In the absence of a
unique marker to deﬁne SSCs, we used Prx1, a marker of the
mesenchymal lineage in developing limbs34,35. BMSCs were
obtained by ﬂushing bone marrow of tibias and femurs followed
by lineage depletion. Remaining long bones free of bone marrow
were placed in culture and PCs were let to grow out of the bone
explants (Fig. 1a and Supplementary Fig. 1a). In primary cultures
of PCs and BMSCs isolated from Prx1-Cre;YFPﬂ/+ mice, the
populations negative for hematopoietic and endothelial makers
and double-positive for Sca1/CD29 and Sca1/CD10536 were
mostly Prx1-derived YFP-positive (Fig. 1a–b and Supplementary
Fig. 1b). The populations that were positive for hematopoietic
and endothelial makers were mainly YFP-negative (Supplemen-
tary Fig. 1c). By qRT-PCR, Prx1-sorted PCs from Prx1-Cre;
mTmG mice overexpressed markers previously shown to deﬁne
mouse BMSCs, such as PDGFRα37, Gremlin 119, Cxcl128,
Nestin15, but not Leptin Receptor (Leptin R)20,21. Prx1-sorted PCs
also overexpressed the pericyte marker NG238 and did not
overexpress the ﬁbroblast marker Vimentin compared to the
Prx1-negative population39 (Fig. 1c and Supplementary Fig. 1d).
Secondary colony forming efﬁciency assay (CFE) show higher
clonogenicity of PCs compared to BMSCs (Fig. 1d). Cell-growth
analyses revealed higher cell growth of PCs compared with
adherent bone marrow cells (aBM, prior to lineage depletion) and
BMSCs (Fig. 1e). PCs can differentiate in osteogenic, adipogenic,
and chondrogenic lineages in vitro with an increased potential for
chondrogenesis compared to BMSCs and aBM (Fig. 1f).
Common embryonic origin of PCs and BMSCs. BMSCs form
the niche for HSCs and are established within the bone marrow
compartment when cartilage anlagen are vascularized during long
bone development40–42. In mice, this step occurs from the develop-
mental stage E14.5 during the formation of the primary ossiﬁcation
center. Simultaneously, the periosteum forms and will include PCs.
Whether BMSCs and PCs derive from the same pool of mesenchy-
mal cells within each skeletal element or whether BMSCs can be
brought by blood vessels from another local or systemic source is still
not well understood. To address this question, we performed renal
capsule transplantations for cell-lineage analyses. On one hand we
tracked cells derived from transplanted cartilage elements that are not
yet vascularized and do not yet comprise a bone marrow compart-
ment. On the other hand, we tracked cells brought by the wild-type
host vasculature that support the vascularization of cartilage grafts in
the renal capsule43,44 (Fig. 2a). First we transplanted E14.5 Prx1-Cre;
YFPﬂ/+ grafts into wild-type hosts. In fully developed bones 8 weeks
post-transplantation, the PC and BMSC populations positive for
Sca1/CD29/CD105 coincided with the donor-derived YFP-positive
population marked by Prx1 (Fig. 2b and Supplementary Fig. 2a).
Therefore, PCs and BMSCs were both derived from the transplanted
cartilage element. Conversely, after transplantation of E14.5 wild-type
femoral cartilages into Prx1-Cre;YFPﬂ/+ hosts, PC and BMSC
populations positive for Sca1/CD29 were YFP-negative, conﬁrming
that PCs and BMSCs are derived from the graft and not from the
host. These results show that both BMSCs and PCs are derived from
the local Prx1-mesenchymal lineage forming each embryonic skeletal
element and are not brought by blood vessels during the establish-
ment of the primary ossiﬁcation center (Supplementary Fig. 2b, c).
Local recruitment of Prx1-derived cells during bone repair. The
Prx1-derived cells within adult bones have been shown to
participate in bone repair34,45. We localized Prx1-derived cells
within the intact periosteum and activated periosteum 3 days
post-fracture in adult Prx1-Cre;mTmG mice in which Prx1-
derived cells are GFP-positive and all other cells are Tomato-
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positive (Fig. 2c). In the activated periosteum, we detected Prx1-
derived cells also marked by CD29 (Fig. 2c, Merge). By day 14
post-fracture, all cells contributing to cartilage and bone in the
callus were GFP-positive Prx1-derived, indicating that Prx1
marks all stem/progenitor cells recruited to form the fracture
callus (Fig. 2c). To verify that the signal was due to Cre
recombination during development and not in response to injury,
we performed fractures in Prx1-Cre/ERT2-EGFP mice that
express EGFP under the Prx1 promoter, and observed no GFP
signal in the callus (Fig. 2c). To distinguish the systemic vs. local
recruitment of cells in the callus, we transplanted E14.5 Prx1-Cre;
LacZﬂ/+ femoral cartilage grafts into wild-type renal capsules.
Eight weeks post transplantation, the fractures were performed on
the fully developed bones derived from the grafts and lineage
analyses showed that all bone cells within the fracture callus at
d14 were LacZ-positive donor-derived (Fig. 2d, e). Controls
showed absence of LacZ-positive host-derived osteoblasts/osteo-
cytes in the callus, when wild type E14.5 femoral grafts were
transplanted in Prx1-Cre;LacZﬂ/+ hosts (Supplementary Fig. 2d,
e). Although several studies have suggested a potential systemic
recruitment of SSCs for bone repair46, these results show that this
systemic recruitment does not occur for endogenous bone repair
and that the Prx1-derived cells forming the fracture callus are all
recruited locally.
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Higher regenerative capacity of PCs compared to BMSCs. To
directly compare the regenerative potential of PCs and BMSCs to
bone repair in vivo, we transplanted GFP-labeled PCs and BMSCs
in the fracture site of wild-type adult mice for in vivo lineage
tracing (Fig. 3a). By day 7-post fracture (d7), transplanted PCs
were found in the center of the callus and showed increased
contribution to the callus compared to BMSCs (Fig. 3b and
Supplementary Fig. 3a). Similar results were obtained for aBM
and BMSC populations indicating that cell depletion of bone
marrow cells did not compromise their biological activity (Sup-
plementary Fig. 3a). This increased contribution of PCs was not
due to changes in cell proliferation or cell death compared with
BMSCs (Supplementary Fig. 3b and c). The majority of BMSCs
stayed at the periphery of the callus and PCs integrated far into
the callus and cartilage by day 10 (Fig. 3b and Supplementary
Fig. 3b, BMSCs right panel). Wound healing assays showed that
PCs migrated faster than BMSCs in vitro, which could at least in
part explain their higher regenerative potential in vivo (Supple-
mentary Fig. 3d). Lineage analyses of PCs and BMSCs isolated
from Prx1-Cre;mTmG donors showed that PCs derived exclu-
sively from the Prx1-mesenchymal lineage contributed to carti-
lage and bone within the callus, while BMSCs had less potential to
form cartilage and did not participate in forming new bone at
later stages (Fig. 3c).
Molecular proﬁling of the periosteum response to injury. In
order to uncover the molecular signatures of PCs deﬁning their
high regenerative potential compared to BMSCs, we performed
microarray analyses of PCs and BMSCs isolated from un-injured
(d0) and injured (day 3 post-fracture) tibias (Fig. 4a). Sample
clustering showed that all biological replicates clustered together
and that PCs from un-injured bone (PCd0) are a distinct popu-
lation compared to other groups in particular to BMSCd0. After
fracture, PCd3 are closer to BMSCd3 (Fig. 4b). To identify gene
sets that distinguish PCs and BMSCs before or after injury, we
performed GSEA analyses comparing either PCd0 vs. BMSCd0 or
PCd3 vs. BMSCd3. At both d0 and d3 post-fracture, PCs share
common GO categories such as “stemness”, “limb development”,
and “ECM”. In contrary, BMSCs are enriched in GO categories
such as “downregulation of stemness”, “bone resorption”, and
“immune and hematopoietic lineage” (Fig. 4c, d and Supple-
mentary Fig. 4a, b). The number of differentially expressed genes
in response to injury was greater in PCs compared to BMSCs
(Fig. 4e). We then focused on genes speciﬁcally upregulated in
PCs after fracture, but not in BMSCs and found 203 genes
deﬁning the “periosteum response to injury” (PRI) gene set
(Fig. 4f). GSEA analysis comparing PCs and BMSCs showed that
PRI genes are enriched in ﬁve different functions (Fig. 4g, in red).
In order to ﬁnd candidate genes that confer higher regenerative
capacities to PCs, we excluded the “stemness” GO categories and
merged “response to external stimulus” and “regulation of
external stimulus” into “external stimulus”. We intersected the
“external stimulus”, “matrisome”, and “extracellular space” gene
sets to identify 9 candidate genes of interest (Fig. 4h). We focused
on Periostin (Postn) gene previously described as being speciﬁ-
cally expressed within periosteum47. Among the “Postn-linked
genes” (complete list of Postn-linked genes in Supplementary
Table 3), 6 genes were found in common with the PRI gene set
and belong to the matricellular protein and small leucin rich
proteoglycan families (Fig. 4i and Supplementary Table 3).
Together, these ﬁndings reveal that PCs and BMSCs have distinct
molecular proﬁles and that PCs are more responsive to bone
injury. The molecular response to injury is marked in PCs with
the early upregulation of genes encoding ECM proteins, which
play important roles in cell–matrix interactions and may be key
elements for SSC activation after bone injury.
Lack of Periostin impairs periosteum function and bone
healing. To elucidate the role of the matricellular protein
Periostin in the periosteal response to injury, we analyzed
Periostin (Postn) expression by qRT-PCR and immuno-
ﬂuorescence. qRT-PCR analyses of PCs and BMSCs in un-injured
tibias and tibias 3 days post-injury conﬁrmed the speciﬁc upre-
gulation of Postn gene in PCs at day 3 compared to day 0 and to
BMSCs (Fig. 5a). Periostin-positive cells were detected by
immunoﬂuorescence in the cambial layer of the periosteum along
the un-injured tibia (Fig. 5b). No expression of Periostin was
detected in the uninjured and activated bone marrow and
endosteum (Supplementary Fig. 5a). By qRT-PCR Postn was
upregulated in sorted GFP-positive PCs isolated from Prx1-Cre;
mTmG mice (Fig. 5b). Three days after fracture, Periostin was
highly expressed in the cambial cell layer of the activated peri-
osteum also containing CD29 expressing cells. By day 14, Peri-
ostin was expressed at the junction between late hypertrophic
cartilage and bone, and by osteoblasts and osteocytes in the new
bone matrix. By 28 days, Periostin was detected in the newly
formed periosteum at the periphery of the ossiﬁed callus (Fig. 5b).
To functionally assess the role of Periostin during bone repair, we
induced tibial fractures in wild-type controls (WT) and Periostin
KO (KO) mice that have been reported to exhibit post-natal
growth retardation and skeletal defects including reduced trabe-
cular bone density in long bones48. Periostin KO mice exhibit
impaired bone regeneration marked by reduced callus size and
bone volume throughout all stages of repair. Periostin KO mice
failed to achieve maximum cartilage volume by day 10 followed
by delayed cartilage resorption, leading to ﬁbrosis and a non-
union at day 28 (Fig. 5c, d). Periostin KO mice also displayed
abnormal repair of unicortical bone defects that heal through
Fig. 1 FACS and in vitro analyses of PCs and BMSCs. a Experimental design of periosteal cells (PCs) and bone marrow stromal cells/skeletal stem cells
(BMSCs) cultures from Prx1-Cre;YFPﬂ/+ or Prx1-Cre;mTmG mouse hindlimbs. Bone marrow cells were ﬂushed from hindlimbs and plated to obtain adherent
bone marrow cells (aBM). After expansion, lineage depletion was performed to isolate BMSCs with no further passage. The ﬂushed bones were placed in
culture to isolate in one step the PCs migrating out of the explants. b Flow cytometry analyses of PCs and BMSCs isolated from Prx1-Cre;YFPﬂ/+ mice. PCs
and BMSCs negative for endothelial/hematopoietic markers (CD31, CD11b, CD34, and CD45) and double-positive for Sca1/CD29 are largely YFP+
(derived from Prx1-mesenchymal lineage). c Quantitative RT-PCR analyses of FACS sorted GFP-positive and GFP-negative PCs and BMSCs isolated from
Prx1-Cre;mTmGmice. Results show overexpression of the markers PDGFRα, Gremlin1, Cxcl12, and Nestin and to a lesser extent NG2 in GFP-positive compared
to GFP-negative PCs, but not LeptinR. d CFE assays showing PCs forming colonies at cell density as low as 400 cells/cm2 14 days after plating and BMSCs
at 2000 cells/cm2 14 days after plating. Colonies were stained with Giemsa blue and counted under microscope. e Cell-growth assay shows that PCs grow
faster than adherent bone marrow cells (aBM) and BMSCs. The cells were plated at the same density (105 cells/dish) and counted every day during the
ﬁrst two days then every two days for 12 days (* represents the comparison between PCs and aBM, $ represents the comparison between PCs and
BMSCs). f In vitro differentiation of PCs and BMSCs into osteogenic (3 weeks), adipogenic (3 weeks), and chondrogenic (2 weeks) lineages as shown by
alizarin red S, Oil red O, and alcian blue staining, respectively. Due to the poor chondrogenic capacity of BMSCs, aBM were assessed for chondrogenesis.
Statistical differences between the groups (n= 3 or 4 per group) were determined using Mann–Whitney test (*,$ p≤ 0.05, **,$$ p < 0.001,
***,$$$ p < 0.0005). All data represent mean ± SD
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direct bone formation indicating that healing via both intra-
membranous and endochondral ossiﬁcation is affected in the
absence of Periostin (Supplementary Fig. 5b, c). To assess the
speciﬁc impact of Periostin gene invalidation on the periosteum,
GFP-wild type or -Periostin KO periosteum grafts were trans-
planted at the fracture site of wild-type mice (Fig. 6a). Periostin
KO periosteal grafts exhibit a decreased contribution to repair in
the wild-type environment compared to WT grafts, thus Periostin
is essential for periosteum activation and contribution to bone
repair (Fig. 6b).
To determine if the defective periosteum response to fracture
in Periostin KO mice was linked to impaired PCs, we isolated
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activated PCs from wild-type and Periostin KO mice 3 days after
tibial fracture. The capacity of Periostin KO PCs to form clones
was decreased compared to WT in CFE assays (Fig. 6c). Periostin
KO PCs had impaired osteogenesis and adipogenesis compared to
wild-type PCs in vitro, although chondrogenic potential was not
affected (Fig. 6d). By qRT-PCR the Periostin-linked genes,
Lumican, Decorin, Osteoglycin, Thrombospondin 2,and Dermato-
pontin upregulated in PCs in response to injury and/or encoding
ECM proteins (Fig. 4i and Supplementary Table 3) showed
decreased expression in Periostin KO PCs compared to wild type
(Fig. 6e). Endoglin 1 expression was upregulated in Periostin KO
PCs compared to wild type and the expression of Asporin,
Fibrillin 1, Tenascin C, Biglycan, SPARC, and Col3a1 was not
affected (Fig. 6e). The expression of these genes in Periostin KO
BMSCs compared to wild type was not affected (Supplementary
Fig. 5d). These results indicate that Periostin KO PCs have
deﬁcient stem cell properties in vitro and decreased expression of
other ECM proteins that are normally speciﬁcally upregulated in
PCs in response to injury. We then assessed the ability of wild-
type PCs to rescue impaired bone healing in Periostin KO mice
(Fig. 6f). GFP-wild-type trans-planted PCs showed high expres-
sion of Periostin and great capacity to integrate into cartilage
(Fig. 6g). Bone volume was increased (WT in KO) compared to
controls (KO in KO) and cartilage volume was decreased
indicating a partial rescue of the phenotype (Fig. 6h).
Periostin is required to maintain the pool of PCs. To assess
more directly the role of Periostin in regulating PCs and their
periosteum niche, we used periosteum transplantation (Fig. 7a).
We ﬁrst assessed whether periosteum contains cells that were able
to repair bone and re-populate the periosteum after injury. After
transplantation of GFP periosteal grafts at the fracture site of
wild-type hosts (Fig. 7a)32, periosteum-derived GFP-positive cells
largely contributed to cartilage in the callus, and rare GFP-
positive cells were localized in the newly formed periosteum by
d28 (Fig. 7b). To evaluate the GFP-positive cells that persisted in
the callus, we isolated PCs and BMSCs from ossiﬁed calluses after
transplantation. GFP-positive cells that were negative for hema-
topoietic and endothelial marker, and positive for Sca1/CD29,
were only detected in PCs, but not in BMSCs cultures (Fig. 7c).
This indicated that PCs within GFP donor periosteum could
repopulate the newly formed periosteum. Following a second
injury, these rare GFP-positive PCs could be re-activated to
contribute to bone repair and were detected within cartilage and
bone by day 7 (Fig. 7b). By day 28, rare GFP-positive cells were
again detected in the new periosteum indicating the ability of PCs
to re-populate the periosteum after the second injury (Fig. 7b). In
a third cycle of injury, these re-activated PCs could again
contribute to cartilage within the callus (Fig. 7b). Quantitative
analyses revealed the ability of PCs to expand extensively from
periosteum in the 3 cycles of injuries (Supplementary Fig. 6a).
The contribution to repair of these rare PCs within the new
periosteum did not decrease between the second and third injury
cycles, indicating that the contribution was not due to a popu-
lation of progenitor cells that would be exhausted overtime
(Supplementary Fig. 6a). When we performed the same experi-
ment with Periostin KO grafts into wild-type hosts, the ability of
PCs to persist in the new periosteum after fracture and contribute
to repair in a second injury cycle was abolished, leading to
defective callus formation and ﬁbrosis (Fig. 7d). Further, trans-
plantation of Periostin KO grafts into a Periostin KO fracture site
ampliﬁed the bone healing defect as shown by the complete
absence of callus formation and bridging (Supplementary Fig. 6b
as compared to the phenotype shown in Fig. 5d). Since we did not
detect decreased cell proliferation in the periosteum of Periostin
KO mice (Supplementary Fig. 6c), these results show that the
Periostin KO phenotype is not due to a deﬁcient proliferation, but
the inability of PCs to maintain a pool of PCs in the periosteum
and support bone healing in the absence of Periostin.
Discussion
Bone regeneration is a well-orchestrated process allowing the
bone to recover its proper shape and functions without the for-
mation of scar tissue. Skeletal stem cells are activated in the early
steps of bone regeneration and are the basis for this extraordinary
capacity of bone to regenerate, but their endogenous origins and
the mechanisms of activation are still poorly understood. Many
studies have focused on the characterization of BMSCs, which are
currently used in cell-based therapy approaches in orthopedics. In
this study, we have identiﬁed that PCs have an enhanced capacity
for cell growth and clonogenicity, as well as superior regenerative
capacities compared to BMSCs. In microarray analyses, PCs have
the key characteristics of SSCs, since they express “stemness” and
“limb or skeletal system development” gene sets. In contrast,
BMSCs are enriched in GO categories, such as “downregulation
of stemness”, “bone resorption” and “immune and hematopoietic
lineage”, suggesting that these cells play an indirect role during
bone repair. Previous reports suggested that endogenous BMSCs
are restricted to the bone marrow compartment during bone
repair and indirectly stimulate healing via the secretion of growth
factors32,49. Their role in regulating hematopoiesis and bone
resorption remains to be further addressed in the context of bone
repair. We show here that after transplantation at an injury site,
BMSCs have reduced capacity to form cartilage and bone during
skeletal regeneration compared to PCs that show great engraft-
ment capacity further revealing the stem cell properties of PCs.
Fig. 2 PCs and BMSCs derive from the Prx1-mesenchymal lineage. a Experimental design for renal capsule transplantations. Femoral cartilages before
vascular invasion were isolated from E14.5 Prx1-Cre;YFPﬂ/+ embryos and transplanted under the renal capsule of wild-type hosts. PCs and BMSCs were
isolated from mature skeletal elements 8 weeks post-transplantation as shown in Fig. 1a. b Flow cytometry analyses of PCs and BMSCs isolated from Prx1-
Cre;YFPﬂ/+ mature skeletal elements grown under renal capsule. Both PCs and BMSCs that are negative for endothelial/hematopoietic markers (CD31,
CD11b, CD34, and CD45) and positive for Sca1/CD29 are mostly YFP-positive (Prx1-donor-derived) (n= 3 per group). c Localization of Prx1-derived cells
in the periosteum and fracture callus of Prx1-Cre;mTmGmouse. The un-injured periosteum is derived from Prx1-lineage (GFP+). In the activated periosteum
at day 3 post fracture, some Prx1-derived cells (GFP/pointed by green arrows) colocalize with CD29-positive cells (Merge CD29+ GFP+/pointed by white
arrows). In the fracture callus (d14), all chondrocytes and osteoblasts/osteocytes are derived from Prx1-lineage (GFP+). The fractures performed on Prx1-
Cre/ERT2,-EGFP mice, where EGFP is expressed under the Prx1 promoter, show no GFP signal in the callus. d Experimental design for cell-lineage analyses
of Prx1-derived cells during bone regeneration in renal capsule. Femoral cartilages were isolated from E14.5 Prx1-Cre+/−;LacZﬂ/+ embryos and transplanted
under the renal capsule of wild-type hosts. After 8 weeks, mature femurs underwent osteotomy and were collected at d14 post-fracture for cell-lineage
tracing. e TC and Xgal/TRAP double-staining on longitudinal sections of Prx1-Cre+/−;LacZﬂ/+ fractured femurs in wild-type hosts (top) showing new bone
within the callus entirely donor-derived, i.e., LacZ+ TRAP− (black arrowheads: osteocytes) and some osteoclasts (TRAP+ LacZ+ with endogenous beta-
galactosidase activity). Scale bar: 0.5 mm. TC: Masson’s trichrome, TRAP: Tartrate resistant acid phosphatase, m: muscle, c: cortex, po: periosteum, bm:
bone marrow, cal: callus, ca: cartilage, white dashed line: callus, orange lightning bolt: fracture, orange arrow: fracture site, black arrow: points to the
periosteum, black arrowhead: osteocytes in new bone
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The difﬁculty in deﬁning adult SSC populations and their
respective functions is due to their high heterogeneity and lack of
speciﬁc markers to distinguish their tissue origins. In the past few
years several markers have been identiﬁed to characterize SSCs
during bone development, growth, and repair12–21. Some of these
markers may deﬁne subpopulations rather than unique popula-
tions and do not distinguish the origin of cells that are marked in
the fracture callus, in particular periosteum vs. bone marrow. We
show using the renal capsule transplantation approach that PCs
and BMSCs are derived from a common embryonic mesenchymal
lineage, but segregate in two different bone compartments during
endochondral ossiﬁcation to acquire different functions in adult
bones. In the bone marrow compartment, BMSCs constitute the
HSC niche, regulate bone turnover, and have immunomodulatory
and paracrine functions during bone maintenance and repair. In
the periosteum compartment, PCs are more directly involved in
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bone repair by forming cartilage and bone in the callus, while the
role of PCs in other periosteum functions remains to be further
characterized. The renal capsule model also provided strong
evidence that systemic recruitment of cells during bone repair is
negligible.
A hallmark of adult stem cells is their ability to self renew after
injury. Self-renewal capacity has been established for other adult
stem cells after tissue injury to show their ability to maintain a
pool of stem cells within the same anatomical location50. The
ability of SSCs to self renew has never been addressed in the
context of bone repair until now. Sacchetti and collaborators
reported that BMSCs can form de novo a bone marrow stroma
organizing a hematopoietic environment surrounded by bone
tissue after subcutaneous transplantation11. This model of het-
erotopic bone formation, however, does not reproduce the ade-
quate environment to assess PC renewal after bone injury.
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Therefore, we designed a strategy based on periosteal grafting and
subsequent injuries to speciﬁcally address the capacity of PCs to
contribute to repair and repopulate the periosteum cell com-
partment after the repair process is completed. We show that
PCs, in addition to their enhanced capacity to regenerate bone
after transplantation, can maintain a pool of PCs within perios-
teum after injury and are mobilized again after subsequent
injuries to repair bone. A similar approach based on single-
muscle ﬁber transplantation was originally used to show extensive
expansion to reform new muscle ﬁbers in situ and self-renewal
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capacity of satellite cells51. This was not the case after trans-
plantation of myoblasts, the muscle progenitors, which cannot
contribute to repair and self-renew52. The fact that a small
number of PCs within the initial periosteal graft can largely
contribute to cartilage, give rise to rare PCs within the new
periosteum and again largely contribute to cartilage in the next
injury cycle indicates the presence of SSCs within the periosteum.
Proliferation of progenitors could not provide a sufﬁcient source
of cells after three consecutive rounds of injury and repair, as they
would disappear overtime. Furthermore, we provide evidence that
this capacity of PCs to re-integrate the newly formed periosteum
and contribute to repair after a second injury is abolished in the
absence of Periostin without affecting the proliferation of PCs in
response to injury. These data show that periosteum contains
stem cells that can self renew during several injury cycles and
Periostin is required for this self-renewal capacity by regulating
the periosteal niche of SSCs. More investigation will be required
in the future to identify speciﬁc markers for the periosteal stem
cell population and follow SSC activation and self-renewal at the
single-cell level within periosteum in vivo. More data will also be
needed to compare the markers and tissue localization of PCs and
BMSCs in mouse and human, as there are already known dif-
ferences for BMSCs11,36,53.
An important question to elucidate is how SSCs are activated
in response to injury. Our microarray data highlight several ECM
proteins that are upregulated in PCs at day 3 post fracture.
Within these ECM proteins, we discovered Periostin, a matri-
cellular protein regulating cell–cell and cell–matrix interactions.
Periostin is highly expressed during development and in adult
tissues submitted to mechanical stress, injury or other patholo-
gical conditions54–56. Periostin plays a crucial role in inﬂamma-
tory and tumor microenvironments57–60. In cancer, Periostin
correlates with bad prognosis61 and Periostin present in the
metastatic niche supports cancer stem cell self-renewal and
metastatic colonization57. In response to bone injury, we show
that Periostin and other ECM proteins linked to Periostin are
upregulated in PCs and Periostin is crucial for adequate bone
repair. In mice lacking Periostin, some of these ECM proteins are
downregulated in PCs, suggesting that Periostin and Periostin-
associated ECM proteins all contribute to PC activation and niche
regulation in response to injury, allowing periosteal activation
(Supplementary Fig. 7). Our results also re-enforce the impor-
tance of a local periosteal response at the injury site to allow callus
formation and bone repair. The local activation of PCs is
necessary for the bone repair process to occur and we show that a
local deﬁciency in this PC pool in Periostin KO periosteum is
sufﬁcient to delay repair and induce non-union.
In conclusion, our results reveal the presence of SSCs within
periosteum with higher regenerative potential compared to
BMSCs. Although PCs and BMSCs derive from common
mesenchymal progenitors during bone development and growth,
the periosteum environment is essential to confer greater regen-
erative properties to PCs. We show that PCs and their perios-
teum niche are two key components that act locally to allow callus
formation and bone bridging for fracture consolidation. Fur-
thermore, PCs, and the ECM components that they produce,
including Periostin, are essential for periosteum activation and
deﬁne the enhanced regenerative potential of PCs. Together, the
roles of PCs illustrated in this study will help refocus investigation
on the periosteum to elucidate numerous bone phenotypes
associated with PCs rather than BMSCs defects. The skeleton
possesses high regenerative capacities, yet our understanding of
SSC origins, recruitment, and functions for the repair of this
central organ system will necessitate more investigation of the
periosteum microenvironment to ﬁnd novel strategies to treat
skeletal repair defects and bone diseases.
Methods
Mice. C57BL/6ScNj, betaactin‐GFP (GFP), Prx1-Cre, Rosa-tdTomato-EGFP
(mTmG), R26ReYFP, and R26ReLacZ transgenic and reporter mice were obtained
from Jackson Laboratory (Bar Harbor, ME). Prx1-Cre/ERT2-EGFP mice were
provided by Dr. S. Murakami34. Periostin null mice from Simon J. Conway
laboratory were crossed with the GFP mice for lineage tracing48. The mice were
bred and genotyped in our laboratory. Five to eight-week-old mice were used for
in vitro experiments and more than two-month-old for in vivo experiments. All
mouse primers for PCR genotyping (Supplementary Table 1) were purchased from
Euroﬁns Scientiﬁc (Euroﬁns, Luxembourg). All procedures were approved by the
Paris Descartes University Ethical Committee. No speciﬁc randomization methods
were used for the study. However, experimental groups were homogeneous and
composed of equivalent animals based on gender, age, and genotype. For each
experimental group, the mice were from different litters and samples obtained from
multiple experiments (>2) to generate biological replicates.
Primary cultures of PCs and BMSCs. BMSCs and PCs were harvested from tibias
and femurs of un-injured mice (d0) or from tibias 3 days post fracture (d3). The
mice were killed and their hindlimbs dissected. After removing the epiphyses,
bones were ﬂushed to isolate total bone marrow cells and aBM were expanded in
growth media consisting of MEMα supplemented with 20% lot-selected non-heat-
inactivated FBS, 1% penicillin-streptomycin (Life Technology, Carlsbad, Cali-
fornia), and 10 ng/ml bFGF (R&D, Minneapolis, MN). When conﬂuence was
reached, lineage depletion (CD5, CD45R (B220), CD11b, Anti-Gr-1 (Ly-6G/C),
7–4, and Ter-119 monoclonal antibodies, Miltenyi Biotec, San Diego, CA, ref. 130-
090-858) was performed on aBM to obtain BMSCs that were directly used for
in vitro and in vivo assays without further expansion. Although this step of lineage
depletion is not standard in the literature for bone marrow cells, we chose this
approach to enrich BMSCs with skeletal progenitors in order to obtain a popula-
tion more comparable to PCs for the purpose of this study. Primary PCs were
obtained by explant culture of the remaining ﬂushed bones free of muscles and
tendons. Explants were cultured in growth media and PCs migrated out of the
explanted within 3 days. After 2 weeks, the bones were removed and PCs were
trypsinized and directly used for in vitro and in vivo experiments without further
expansion. To determine if our method of explant culture was optimal to retrieve
PCs without contamination from the endosteum or the bone cortex, we performed
the same procedure by ﬂushing the bone marrow preceded or followed by
Fig. 6 Impaired periosteum in Periostin KO mice. a Experimental design for the isolation of periosteum grafts from GFP or Periostin KO-GFP donors and
transplantation at the fracture site of wild type (WT) hosts for lineage tracing of periosteum-derived cells during bone repair. b SO staining and DAPI/GFP
immunoﬂuorescence on longitudinal callus sections at day 14 reveals decreased contribution KO-GFP grafts (KO in WT) compared to GFP grafts (WT in
WT) (arrowheads). Quantiﬁcation of GFP signal shows decreased volume in callus and cartilage for KO-GFP grafts compared to GFP grafts. Scale bar: 1
mm. c CFE assay on activated PCs isolated from WT and KO mice and plated at 400 cells/cm2 for 14 days. Colonies were stained with Giemsa blue and
counted. d In vitro differentiation assays of activated PCs isolated from WT and KO mice shows osteogenic differentiation (alizarin red S stain) at 2 weeks
for WT PCs, but not for KO PCs (left) and at 5 weeks for WT and KO PCs (right). Adipogenesis (Oil red O) is reduced in KO at 3 weeks and
chondrogenesis (alcian blue stain) at 1 week is similar in WT and KO PCs. e Quantitative RT-PCR analyses of Periostin (Postn)-linked genes, some of them
upregulated in PCs in response to injury and encoding ECM proteins (see Fig. 4i and Supplementary Table 3) inWT-PCs and KO PCs. f Experimental design
for the isolation of activated PCs from GFP or KO-GFP mice and transplantation at the fracture site of KO hosts (WT in KO and KO in KO, respectively). g
Periostin (POSTN/red) immunoﬂuorescence on callus sections after transplantation of WT PCs (GFP/green) in KO hosts. PCs express POSTN when they
integrate into the callus (Merge/Yellow, left and boxes 1 and 2) and stop expressing POSTN when they differentiate (box 2, white arrowhead pointing to
POSTN-negative and GFP-positive chondrocytes). Scale bar: 1 mm. h Histomorphometric analyses of callus, bone, and cartilage volumes at d14. Scale bar: 1
mm. SO: Safranin-O, c: cortex, ca: cartilage, cal: callus, white dashed line: bone, black dashed line: callus, merge: GFP+ cells expressing POSTN. Statistical
differences between the groups were determined using Mann–Whitney test (*p < 0.05) (n= 3 or 4 per group). All data represent mean ± SD
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periosteum scrapping and collagenase D digestion (0.2% collagenase D with 0.25%
Trypsin/EDTA in DMEM+ 1% P/S without serum) for 1 h (Roche, Basel, CH, ref.
11088882001) prior to bone explants culture. In these conditions, the cells did not
grow out of the explants (Supplementary Fig. 1a-ii and 1a-iii).
Flow cytometry analyses and cell sorting. For ﬂow cytometry analyses, the cells
were incubated with CD31-PE-CyTM7 (PECAM-1); CD45-PE-CyTM7 (leukocyte
common antigen, Ly-5); CD11b-PE-CyTM7 (integrin αM chain); CD34-PE-CyTM7
(BD Biosciences, San Jose, CA); CD29-PE, Sca1-APC (Miltenyi Biotec, San Diego,
CA); and CD105-PE (eBioscience, San Diego, CA) (1:200) to label hematopoietic,
endothelial, and mesenchymal lineages. For cell viability, Sytox Blue 1/1000 (Invi-
trogen, Thermo Fischer Scientiﬁc, Waltham, MA) was added. Analyses were per-
formed using BD LSR Fortessa SORP (BD Biosciences, San Jose, CA). For cell sorting,
the cells were resuspended in F10 media (Life Technology, Carlsbad, California)
before sorting with BD FACS Aria II SORP (BD Biosciences, San Jose, CA).
Secondary colony forming efﬁciency assay (CFE). BMSCs obtained after lineage
depletion of aBM and PCs obtained after explant removal were directly plated at a
concentration of 400 or 2000 cells/cm2 in growth media consisting of MEMα
supplemented with 10% FBS, 1% penicillin-streptomycin (Life Technology,
Carlsbad, California), and 10ng/ml bFGF (R&D, Minneapolis, MN) for 14 days.
The medium was changed every 3 days. Clones were ﬁxed for one hour in 70%
ethanol, stained with Giemsa stain (Fluka), and counted under microscope. CFE
was reported in GraphPad Prism v6.0a.
Cell-growth assay. To assess cell growth in vitro, 1.5 105 BMSCs obtained after
lineage depletion and PCs after explant removal were directly plated in culture
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dishes and cultured in growth medium. The cells were trypsinized for counting the
ﬁrst two days and then every two days during twelve days. Cell count was reported
in GraphPad Prism v6.0a.
In vitro osteogenic and adipogenic and chondrogenic differentiations. For each
differentiation protocol, BMSCs were used following lineage depletion and PCs
following explant removal without further passage. For osteogenic differentiation,
the cells were plated at conﬂuence in osteogenic medium containing MEMα with
10% FBS supplemented with 0.1 μM dexamethasone, 0.2 mM L-ascorbic acid, and
10 mM glycerol 2-phosphate disodium salt hydrate (Sigma, St. Louis, MO). The
medium was changed every three days during 2–5 weeks, and the cells were stained
with 0.2% alizarin red S (Sigma, St. Louis, MO). For adipogenic differentiation, the
conﬂuent cells were cultured with adipogenic medium containing MEMα with 10%
FBS supplemented with 10 μg/ml insulin, 100 μM indomethacin, 0.5 mM 3-iso-
butyl-1-methylxanthine, and 0.1 μM dexamethasone (Sigma, St. Louis, MO). The
medium was changed every 3 days during 3 weeks and the cells were stained with
Oil Red O solution (Sigma, St. Louis, MO). Nuclei were counterstained with Harris
hematoxylin (DiaPath, Martinengo, Italy). Pictures of lipid droplets were taken
under light microscopy using Leica DM IRB light microscope and LAS
v4.3 software (Leica Microsystems Inc, Buffalo Grove, IL). For chondrogenic dif-
ferentiation, the cells were resuspended at a concentration of 5.105 cells in 200 μl of
growth media and plated as micromass. After 2 h at 37 °C, the cells were covered
with chondrogenic medium containing DMEM with 10% FBS supplemented with
0.1 μM dexamethasone, 100 μg/ml sodium pyruvate, 40 μg/ml L-proline, 50 μg/ml
L-ascorbic acid, 50 mg/ml ITS, and 10 ng/ml TGFβ1. The medium was changed
every 3 days during 1–2 weeks and the cells were stained with Alcian blue (Sigma,
St. Louis, MO).
Wound healing assay. Wound healing assay was performed to assess migration
capacity of cells in vitro. Forty-eight hours before the assay, BMSCs obtained after
lineage depletion and PCs after explant removal were directly plated in culture
inserts in μ-slide 8 well ibiTreat (Biovalley) and cultured in growth media. Before
starting the assay, culture inserts were removed allowing a clear separation between
two migration fronts (wound). A volume of 10 μM of Cytosine β-D-
arabinofuranoside hydrochloride (Sigma, St. Louis, MO) was added in the medium
to inhibit cell mitosis. Wound healing was recorded every 10 minutes over 50 to 72
h using videomicroscopy (Nikon Eclipse Ti-E). Data were analyzed with ICY
software (bioimageanalysis.org) and reported in GraphPad Prism v6.0a.
Fractures and cell transplantations. Closed non-stabilized and open non-
stabilized tibial fractures were performed in the mid-diaphysis under anesthesia
and analgesia2,32. For all surgeries, mice were anesthetized with an intraperitoneal
injection of Médétomidine (1 mg/kg) and Kétamine (50 mg/ml) and received a
subcutaneous injection of Buprenorphine (0,1 mg/kg) for analgesia. For closed
fractures, the tibia was placed on the fracture jig and 460 g weight was dropped
from 14 cm to create a closed, transverse fracture by three-point bending, which
was conﬁrmed by radiography. Opened non-stabilized tibial fractures were pro-
duced by osteotomy. The anterior tibial surface was exposed by separating the bone
from the surrounding muscles. Three holes were drilled in the tibial cortex using a
0.4 mm drill bit and the bone was cut to create the fracture. After surgery, the mice
were revived with a subcutaneous injection of Atipamezole (1 mg/kg) and were
allowed to move freely. The mice then received a second dose of analgesic 12–24 h
after surgery and subsequent doses as needed. For cell transplantations at the
fracture site, 100,000 cells were embedded in a ﬁbrin gel using a Tissucol® kit
(Baxter, France TISSEEL, composed of human ﬁbrinogen 15 mg/ml and thrombin
9 mg/ml) and the cell pellet was transplanted at the time of fracture62.
Cortical bone defects. To assess the impact of Periostin deﬁciency on bone healing
through intramembranous ossiﬁcation, we performed unicortical bone defects
(without breaking the bone) on wild-type and Periostin KO mice as previously
described24. Brieﬂy, after anesthesia and analgesia, the tibial surface was exposed,
and a hole (1 mm in diameter) was drilled into one cortex without drilling into the
opposite cortex. After surgery, the mice were revived as indicated above.
Periosteum grafting. Periosteum grafts isolated from the tibia GFP or Prx1-Cre;
mTmG donor mice were transplanted at the site of open non-stabilized tibial
fractures in 10-week-old wild-type or Periostin KO host mice32. For assessment of
long-term engraftment, successive fractures at one-month interval were performed
at the site of initial bone graft in 5-week-old hosts and fracture calluses were
collected at days 7 and 28. For BMSCs and PCs cultures, day 14 ossiﬁed calluses
were retrieved by dissection. BMSCs were obtained by ﬂushing the bone marrow
cells from the fracture calluses followed by adherence and lineage depletion calluses
as described above. PCs were cultured by explant cultures of remaining ossiﬁed
parts of the fracture calluses. Fracture callus pieces were carefully cleaned and
placed in culture periosteum facing down. PCs and BMSCs were used for cell
sorting and FACS analyses.
Renal capsule transplantation. Femoral grafts containing cartilage anlage sur-
rounded by perichondrium were isolated from E14.5 donor embryos, transplanted
in the renal capsule of adult host mice, and allowed to develop for 8 weeks to form
fully mature bones43. PCs and BMSCs were isolated as described above from bones
derived from Prx1-Cre;YFPﬂ/+ donors transplanted in C57BL/6ScNj (wild type)
hosts and analyzed via ﬂow cytometry as indicated above. For lineage analyses
during bone repair, the bones derived from Prx1-Cre;LacZﬂ/+donors transplanted
in wild-type hosts were fractured by osteotomy under anesthesia by exposing the
kidney capsule and collected 7 or 14 days post fracture for lineage tracing using
Xgal/TRAP staining on tissue sections as previously described63. In control sam-
ples, the genotypes of the donor (wild type) and host (Prx1-Cre;YFPﬂ/+or Prx1-Cre;
LacZﬂ/+) were reversed.
Histomorphometry and cell-lineage analyses. The mice were killed at speciﬁed
time points post fracture. Tibias were ﬁxed in 4% paraformaldehyde, decalciﬁed in
19% EDTA, and processed for histomorphometric analyses of callus, cartilage, and
bone on Safranin-O (SO) and Trichrome (TC) stained sections62,64. Picrosirius
staining was performed on adjacent sections to visualize bone and ﬁbrous tissue.
For quantitative analyses of GFP-transplanted cells in fracture calluses, GFP signal
was analyzed on sections adjacent to Safranin-O and Trichrome using a Zeiss
Imager D1 AX10 light microscope and ZEN software (Carl Zeiss Microscopy
GmbH, Gottinger, Germany).
Immunoﬂuorescence and immunohistochemistry. For PCNA immuno-
ﬂuorescence, the sections were rehydrated, post ﬁxed in 4% paraformaldehyde for
10 min, treated with methanol for 10 min, permeabilized with 0.25% TritonX-100
in PBS, and blocked with 5% Goat serum in 0.25% tritonX-100 in PBS for 15 min.
The sections were then incubated with primary antibody rabbit anti mouse PCNA
1:800 (Cell Signaling, Danvers, MA ref. 13110 s) or non-immune rabbit IgG as
negative control (Invitrogen, Thermo Fischer Scientiﬁc, Waltham, MA ref. 10500
C) O/N at 4 °C. The sections were washed and incubated with secondary antibody
Alexa 546 goat anti rabbit 1:500 (Invitrogen, Thermo Fischer Scientiﬁc, Waltham,
MA ref.11010) in 5% goat serum for one hour at RT, and mounted with Fluor-
omount-G™ with DAPI (eBioscience, San Diego, CA).
For Cleaved Caspase 3 immunoﬂuorescence, the sections were rehydrated, post
ﬁxed in 4% paraformaldehyde for 10 min, permeabilized with 0.25% TritonX-100
in PBS, and blocked with 5% Goat serum in 0.25% tritonX-100 in PBS for one
hour. The sections were then incubated with primary antibody rabbit anti mouse
Fig. 7 No reconstitution of the PC pool in Postn KO periosteum after fracture. a Experimental design for the isolation of periosteum graft from GFP donor
mice and transplantation at the fracture site of wild-type hosts. b SO staining and DAPI/GFP immunoﬂuorescence on longitudinal sections of mouse
fractured tibias post transplantation with GFP periosteum graft. At d28 post fracture (d28-new periosteum), high magniﬁcation shows rare periosteum-
derived GFP+ cells that integrate in the new bone to form osteocytes (white arrow) and in the new periosteum (white arrowheads). After a second fracture
performed at the level of the ﬁrst callus, abundant periosteum-derived GFP+ cells are found in the callus and form cartilage (white arrowheads) and bone
(white arrows) (d7-callus) and few GFP+ cells reintegrate the new periosteum at d28 (white arrowheads) (d28-new periosteum). After a third fracture,
periosteum-derived GFP+ cells can again form cartilage efﬁciently in the callus by day 7 (white arrowhead) (day 7-callus). c Cell sorting and FACS
analyses on PCs and BMSCs isolated from ossiﬁed calluses (d14). PCs and BMSCs derived from the periosteum graft were detected based on the
expression of the GFP (0.06% and 0.01%, respectively). Cell sorting was performed to enrich the population in GFP+ cells (orange box) and FACS
analyses to assess the expression of hematopoietic-endothelial markers (CD11b, CD31, CD45, and CD34) and Sca1/CD29). In BMSCs cultures, GFP+ cells
were all positive for hematopoietic-endothelial markers (100%). For PC cultures, we detected a population that was negative for hematopoietic-endothelial
markers (35.8%) and positive for Sca1/CD29 (35.9%) (n= 2 or 3). d Transplantation of Periostin KO grafts into wild-type hosts. No GFP+ cells are
detected in the new periosteum (d28–new periosteum), and no GFP+ chondrocytes contribute to the callus after a second injury. These Periostin KO grafts
induced ﬁbrosis at the fracture site of wild-type hosts (d7–callus). SO: Safranin-O/Fast Green, PS: Picro Sirius, cal: callus, po: periosteum, nb: new bone, ca:
cartilage, white dashed line: periosteum (d28) or new bone (d7), orange dashed line: callus, yellow line: periosteum transplant, asterisk: cartilage formation
opposite to transplant (n= 4). Scale bar= 1 mm
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Cleaved Caspase 3 1:200 (Cell Signaling, Danvers, MA ref. 9661) or non-immune
rabbit IgG as negative control (Invitrogen, Thermo Fischer Scientiﬁc, Waltham,
MA ref. 10500 C) O/N at 4 °C. The sections were washed and incubated with
secondary antibody Alexa 546 goat anti rabbit 1:800 (Invitrogen, Thermo Fischer
Scientiﬁc, Waltham, MA ref.11010) in 5% goat serum for one hour at RT and
mounted with Fluoromount-G™ with DAPI (eBioscience, San Diego, CA).
For Periostin immunoﬂuorescence, the sections were rehydrated, blocked with
5% donkey serum in PBS one hour at room temperature (RT), and incubated with
primary antibody goat anti mouse Periostin 1:400 (R&D, Minneapolis, MN ref.
AF2955) or non-immune goat IgG as negative control (Life Technology, Carlsbad,
California ref. 026202) overnight (O/N) at 4 °C. The sections were washed and
incubated with secondary antibody Alexa 488 donkey anti goat or Alexa 546
donkey anti goat 1:500 (Invitrogen, Thermo Fischer Scientiﬁc, Waltham, MA ref.
A11055 or ref. A11056) for one hour at RT. Slides were mounted with
Fluoromount-G™ with DAPI (eBioscience, San Diego, CA).
For CD29 immunoﬂuorescence, the sections were rehydrated, post ﬁxed in 4%
paraformaldehyde for 10 min, permeabilized with 0.25% TritonX-100 in PBS, and
blocked with 5% donkey serum in PBS for 15 min. The sections were incubated
with primary antibody goat anti mouse integrinβ1 5 μg/ml (R&D, Minneapolis,
MN, ref. AF2405) or non-immune goat IgG as negative control (Life Technology,
Carlsbad, California ref. 026202) O/N at 4 °C. The sections were washed and
incubated with secondary antibody Alexa 546 donkey anti goat or Alexa 647
donkey anti goat 1:500 (Invitrogen, Thermo Fischer Scientiﬁc, Waltham, MA) in
5% donkey serum for one hour at RT and mounted with Fluoromount-G™ with
DAPI (eBioscience, San Diego, CA).
For BrdU immunochemistry, the mice were beforehand injected with 50 mg/kg
of BrdU (Sigma, St. Louis, MO ref. B5002) in 5% DMSO and their hindlimbs were
harvested three hours later and processed as previously described. The sections
were dehydrated in ethanol baths and antigen retrieval was performed using 2 N
HCl in 0.5% Triton-X100 for 30 min at RT. Endogenous peroxidase activity was
blocked using 3% H2O2 in PBS for 10 min. Sections were blocked in 5% goat serum
in PBS for 1 h and incubated with primary antibody rat anti mouse BrdU 1:200
(Abcam, Cambridge, UK ref. Ab6326) or no primary antibody as negative control,
O/N at 4 °C. The sections were washed and incubated with secondary antibody
biotin goat anti rat 1:500 (Jackson ImmunoResearch, West Grove, PA ref.
112066072) for 1 h at RT. After washing in PBS, the sections were incubated in
Streptavidin-HRP 1:100 (BD Biosciences, San Jose, CA ref. 554066) for 30 min at
RT. Finally, signal was revealed using DAKO kit (Agilent, Santa Clara, CA ref.
K3467) and counterstained with 5% Methyl green. BrdU+ cells were counted
under microscope and reported in GraphPad Prism v6.0a.
RNA isolation and qRT-PCR. Total mRNA extraction from cells was performed
using RNeasy Plus Mini Kit (Qiagen, Germantown, MD) and following manu-
facturer’s instructions. The concentration of extracted RNA was conﬁrmed using a
NanoDrop 2000 UV-Vis Spectrophotometer (Thermo Scientiﬁc, Wilmington, DE).
All mouse primers (Supplementary Table 2) were purchased from Euroﬁns Sci-
entiﬁc (Euroﬁns, Luxembourg). cDNA synthesis was performed using Superscript
III RT, RNaseOUT, Ribonuclease inhibitor, Oligo(dT)12–18, 10 mM dNTP mix,
5X ﬁrst-strand buffer, and 0.1 M DTT, following manufacturer’s instructions
(Thermo Fischer Scientiﬁc, Waltham, MA). Real-time PCR was performed using
SYBR™ Green PCR Master Mix and detected using 7300 Real-Time PCR System
(Thermo Fischer Scientiﬁc, Waltham, MA). Mouse GAPDH was used as an internal
control for all genes.
Microarray analyses. BMSCs and PCs were isolated and puriﬁed from uninjured
tibia (d0) (n= 4) and tibia 3 days post fracture (n= 4). The cells were harvested
and total RNA was extracted using Rneasy Plus mini Kit (Qiagen). RNA quality
was assessed using Agilent Model 2100 Bioanalyzer (Agilent Technologies). Gene
expression analyses were performed using GeneChip Mouse 430 2.0 Array (Affy-
metrix). Fluorescence data were imported into Affymetrix Expression Console and
R Bioconductor analysis software. Data were normalized with RMA method,
groups were compared by Student’s t-test and the results were ﬁltered at p-value
≤5% and fold change ≥1.2. Hierarchical clustering was performed using Multi-
Experiment Viewer software (MeV)65,66. Gene Set Enrichment Analysis (GSEA)
analysis was performed using all normalized probes on “curated gene set” and “GO
gene set” collections of the Molecular Signatures Database v5.2 according to67,68.
Postn-linked gene list was built using STRING database69 (http://string-db.org/cgi/
input.pl?UserId=5bskVvnWAJdi&sessionId=hMz9XrOQGQ4P&input_page_
show_search=on). We used the following parameters: active interaction sources: all
checked; minimum required interaction score: 0.4; maximum number of inter-
actors to show: 1st shell: 100; and 2nd shell: 20. We obtained a list of 93 genes
(Supplementary Table 3).
Statistical analyses. Statistical signiﬁcance was determined with two-sided
Mann–Whitney test and reported in GraphPad Prism v6.0a. P-values were deter-
mined as follows: *,$p ≤ 0.05; **,$$p < 0.001; ***,$$$p < 0.0005. All samples were
included except for fractures that were proximal and/or distal or comminuted
fractures. All analyses were performed using a blind numbering system.
Data availability. The microarray data have been deposited in the ArrayExpress
database under the accession number E-MTAB-6417. All other data are available in
the article and in the supplementary information ﬁles.
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